Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: Pro

J Urol. 2017 Nov;198(5):997-999. doi: 10.1016/j.juro.2017.08.089. Epub 2017 Sep 22.
No abstract available

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / blood
  • Humans
  • Male
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • Risk Assessment / methods*
  • Risk Factors
  • Watchful Waiting*

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen